Keenova’s SMSNA announcement covers Peyronie’s treatment research and a sexual-health screener. Here’s why clinical discussion remains the practical next step.
In an October 8, 2026 announcement, Keenova described three presentations at the Sexual Medicine Society of North America (SMSNA) annual meeting: two addressing XIAFLEX and Peyronie’s disease and one concerning development of a men’s sexual-health screener.
The announcement provides no sample sizes, numerical treatment outcomes or detailed methods. It supplies neither the treatment presentations’ conclusions nor the screener itself or evidence of its effectiveness. The presentation titles also leave patient selection and the wider applicability of the ventral-curvature work unresolved. This is a company-issued announcement, not an independent assessment or an outcomes report.
A 2026 review indexed by Wiley discusses research on collagenase for ventral curvature. It notes that ventral cases were excluded from the initial IMPRESS trials because of theoretical concern about urethral injury. The review also summarizes later single-institution studies.
That history helps explain why a presentation focused on ventral curvature deserves attention. It is a specific evidence question rather than a minor variation in a treatment headline. For a patient discussing options, the relevant issue is how the research relates to the particular concern being assessed.
The distinction also changes how to read the phrase “real-world data.” Here it describes examination of treatment experience. It should direct attention toward the patients and circumstances studied rather than serve as a general endorsement of treatment.
For a man over 35 thinking about healthspan, the practical relevance is straightforward: sexual comfort and function belong in the health conversation. They do not need to sit outside it while strength or body composition receives all the attention.
The research packet supports raising new, changing or troublesome curvature with a qualified clinician. Pain, erectile difficulties or other sexual concerns also provide a reason for discussion. There is no need to turn the meeting coverage into a personal diagnosis before making that appointment.
This fits a broader view of sexual wellbeing after 35. The immediate goal is to describe what is happening and what matters to you. Selecting an intervention is a separate clinical decision.
A structured discussion can begin with the observations already available to you. The useful material is not a diagnosis borrowed from an article. It is the change you have noticed and the way it affects comfort or sexual wellbeing.
Relevant subjects include:
These are discussion topics rather than a self-scoring system. They do not establish Peyronie’s disease or determine which treatment fits. Their purpose is to make the reason for the appointment clear.
You also do not need to decide whether the concern is “serious enough” by comparing yourself with someone else’s account. The practical takeaway in the supplied research is to bring bothersome symptoms into care rather than wait for a particular severity threshold. That keeps the focus on your experience instead of a number borrowed from a headline.
The word “nonsurgical” should not carry the whole safety story. The Wiley review identifies risks of corporal rupture and severe hematoma with collagenase treatment. The safety information accompanying the announcement also describes a restricted program and local reactions including hematoma, swelling and pain.
Those cautions belong in the same conversation as treatment potential. A nonsurgical option is not automatically a low-risk option or a suitable choice for every form of curvature. Individual treatment decisions require qualified clinical assessment and attention to the official safety information.
For someone reading the news before an appointment, a useful question is: “How does the evidence apply to my situation, and what risks matter in deciding whether this option fits?” That invites a discussion about both suitability and safety. It does not start from the assumption that the treatment named in the news is the treatment to pursue.
The practical adjustment is therefore not to seek a particular procedure on the strength of a presentation title. It is to bring the concern into care with room for an assessment that may lead in a different direction.
Keenova describes its screening project as a clinician-patient communication resource. In the company announcement, Jesse Mills, MD, said that treatment options and practical tools for identifying concerns and engaging patients both matter in men’s sexual health.
The editorial value of that idea is the attention it gives to the conversation itself. Treatment research and communication work address different parts of care. One concerns an intervention; the other concerns how a concern gets recognized and discussed.
For the reader, the useful principle is not to wait for a named tool before speaking. An ordinary appointment can include a direct statement that curvature or sexual symptoms are affecting comfort or confidence. A conversation can begin with a concern rather than a completed questionnaire.
For gay men, useful sexual-health guidance should leave room for different relationships and different meanings of satisfying intimacy. No single sexual role or relationship arrangement should be presumed. Nor should a particular body type set the standard for whose concerns deserve attention.
In practical terms, that means describing the impact that matters to you rather than trying to fit a generic account of male sexual performance. Comfort may be the priority. For someone else it may be erectile function or confidence during intimacy. These priorities can sit together without becoming a test of masculinity.
This is also where thinking about healthspan as everyday capability becomes useful. Looking good and staying strong can remain meaningful goals. Making room for sexual wellbeing does not require setting either aside.
This news belongs on the appointment agenda rather than the shopping list. Its practical value is a reason to raise a concern and ask informed questions about assessment. It is not a reason to turn a conference announcement into a personal treatment plan.
For a man balancing training and work with a full personal life, that is a manageable shift in attention. Bring the symptom into the same adult health conversation as your other priorities. You do not have to solve it privately before asking for professional input.
Treat this news as a reason to discuss new or bothersome curvature and sexual symptoms with a qualified clinician, not as a reason to diagnose yourself or select a treatment.
Peyronie’s meeting headlines can turn unanswered treatment questions into premature certainty; GayFitLab separates credible evidence from medical hype. When generic men’s health advice misses gay social and sexual-health context, its coverage gives gay men 35+ a clearer basis for weighing comfort and intimacy alongside their wider health priorities.
Stay connected for research-led guidance on fitness, body composition, skin, grooming, vitality, sexual wellbeing, relationships and healthy aging. Clear ideas for gay men 35+ who want to look good, feel strong and age with confidence.
Build habits and systems that support clear thinking, steady energy and long term capacity throughout a demanding career.
explore the Blog
